FAM27E5 as A Potential Drug Target and Biomarker for Diseases

Target Name: FAM27E5

NCBI ID: G284123

FAM27E5

Other Name(s): FAM27L | Family with sequence similarity E5 | family with sequence similarity E5

FAM27E5 as A Potential Drug Target and Biomarker for Diseases

FAM27E5 (FAM27L), a protein located in the endoplasmic reticulum, has been identified as a potential drug target and biomarker for various diseases, including neurodegenerative disorders, autoimmune diseases, and metabolic diseases. Its unique structure and subcellular localization make it an attractive target for small molecules and other therapeutic agents.

The endoplasmic reticulum (ER) is a complex network of protein channels and transport systems that plays a vital role in the regulation of intracellular protein levels and their interactions. FAM27E5 is a member of the FAM27 family of proteins, which are known to regulate the levels of various proteins in the ER. These proteins act as either oncogenes or tumor suppressors, depending on their expression level and context. FAM27E5 is unique among its family members due to its subcellular localization in the ER, as most FAM27 proteins are cytoplasmic.

FAM27E5's subcellular localization in the ER allows it to interact with various intracellular signaling pathways and targets. One of its unique features is its ability to interact with the protein kinase PDK4, which is a key regulator of cell proliferation and survival. This interaction between FAM27E5 and PDK4 has been implicated in the development and progression of various diseases, including cancer.

FAM27E5's role in cell signaling pathways also makes it a potential target for small molecules that can modulate its activity. Many diseases, including neurodegenerative disorders and autoimmune diseases, are characterized by the misregulation of signaling pathways and the production of aberrant proteins. By targeting FAM27E5 and modulating its activity, small molecules can potentially treat these diseases.

FAM27E5's subcellular localization in the ER also makes it a unique biomarker for certain diseases. Its expression is often reduced in the brains of patients with neurodegenerative disorders, making it a potential target for diagnostic tests and therapies. Additionally, its decreased expression has been observed in the blood of patients with autoimmune diseases, suggesting that it may serve as a diagnostic or therapeutic target in these conditions.

In conclusion, FAM27E5 is a protein with great potential as a drug target and biomarker for various diseases. Its unique subcellular localization in the ER and its interaction with PDK4 make it an attractive target for small molecules. Further research is needed to fully understand its role in disease progression and its potential as a therapeutic agent.

Protein Name: Family With Sequence Similarity E5

The "FAM27E5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM27E5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets